Literature DB >> 26416860

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.

Douglas J Biedenbach1, Daryl J Hoban1, Edina Reiszner2, Sushmita D Lahiri2, Richard A Alm2, Daniel F Sahm3, Samuel K Bouchillon1, Jane E Ambler2.   

Abstract

The in vitro activities of ceftaroline and comparators, using broth microdilution, were determined against 1,066 Staphylococcus aureus isolates from hospitalized patients. Seventeen medical centers from Latin American countries contributed isolates. Methicillin-resistant S. aureus (MRSA) percentages ranged from 46% (Brazil) to 62% (Argentina). All methicillin-susceptible S. aureus (MSSA) isolates were susceptible to ceftaroline. Ceftaroline activity against MRSA varied with MIC90s of 0.5 (Venezuela) to 2 (Brazil, Chile, and Colombia) μg/ml, which was the highest MIC value. ST-5 was the most common sequence type.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26416860      PMCID： PMC4649166          DOI： 10.1128/AAC.01833-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Authors:  Thomas P Lodise; Donald E Low
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

Review 2.  Pneumonia caused by methicillin-resistant Staphylococcus aureus.

Authors:  Ethan Rubinstein; Marin H Kollef; Dilip Nathwani
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

Review 3.  Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 4.  Methicillin-resistant Staphylococcus aureus pneumonia in adults.

Authors:  Christian Woods; Gene Colice
Journal:  Expert Rev Respir Med       Date:  2014-07-17       Impact factor: 3.772

Review 5.  Summary of ceftaroline fosamil clinical trial studies and clinical safety.

Authors:  Thomas M File; Mark H Wilcox; Gary E Stein
Journal:  Clin Infect Dis       Date:  2012-09       Impact factor: 9.079

6.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

7.  Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.

Authors:  Julian J Goodman; Stanley I Martin
Journal:  Ther Clin Risk Manag       Date:  2012-03-26       Impact factor: 2.423

8.  Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics.

Authors:  Jennifer Fishovitz; Alzoray Rojas-Altuve; Lisandro H Otero; Matthew Dawley; Cesar Carrasco-López; Mayland Chang; Juan A Hermoso; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2014-07-02       Impact factor: 15.419

9.  Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals.

Authors:  Manal Tadros; Victoria Williams; Brenda L Coleman; Allison J McGeer; Shariq Haider; Christine Lee; Harris Iacovides; Ethan Rubinstein; Michael John; Lynn Johnston; Shelly McNeil; Kevin Katz; Nancy Laffin; Kathryn N Suh; Jeff Powis; Stephanie Smith; Geoff Taylor; Christine Watt; Andrew E Simor
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

10.  Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.

Authors:  Paul D Santos; Amanda Davis; Alena Jandourek; Alexander Smith; H David Friedland
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714
View more
  9 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline Fosamil.

Authors:  Peter Matzneller; Edith Lackner; Heimo Lagler; Beatrix Wulkersdorfer; Zoe Österreicher; Markus Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 3.  Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.

Authors:  Richard R Watkins; Marisa Holubar; Michael Z David
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

4.  Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.

Authors:  Silvio Vega; Michael J Dowzicky
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-07-12       Impact factor: 3.944

5.  In vitro and in vivo activity of d-serine in combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.

Authors:  Qing Wang; Yuemeng Lv; Jing Pang; Xue Li; Xi Lu; Xiukun Wang; Xinxin Hu; Tongying Nie; Xinyi Yang; Yan Q Xiong; Jiandong Jiang; Congran Li; Xuefu You
Journal:  Acta Pharm Sin B       Date:  2019-01-31       Impact factor: 11.413

Review 6.  Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms.

Authors:  Despoina Koulenti; Elena Xu; Isaac Yin Sum Mok; Andrew Song; Drosos E Karageorgopoulos; Apostolos Armaganidis; Jeffrey Lipman; Sotirios Tsiodras
Journal:  Microorganisms       Date:  2019-08-18

7.  Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.

Authors:  Thaina Miranda da Costa; Priscylla Guimarães Migueres Morgado; Fernanda Sampaio Cavalcante; Andreia Paredes Damasco; Simone Aranha Nouér; Kátia Regina Netto Dos Santos
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

Review 8.  PBP4: A New Perspective on Staphylococcus aureus β-Lactam Resistance.

Authors:  Thaina M da Costa; Carolina R de Oliveira; Henry F Chambers; Som S Chatterjee
Journal:  Microorganisms       Date:  2018-06-22

9.  The use of extrapolation based on modeling and simulation to support high-dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft-tissue infections.

Authors:  Phylinda L S Chan; Lynn McFadyen; Andrea Quaye; Heidi Leister-Tebbe; Victoria M Hendrick; Jennifer Hammond; Susan Raber
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.